KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 12,640
+510 (4.20%)
At close: Jan 23, 2026
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 137.86 billion as of January 23, 2026. Its market cap has decreased by -18.97% in one year.
Market Cap
137.86B
Enterprise Value
142.67B
Revenue
90.11B
Ranking
n/a
PE Ratio
791.60
Stock Price
12,640.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 137.86B, a decrease of -24.99%. That is a compound annual growth rate of -5.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 137.86B | -2.77% |
| Dec 30, 2025 | 141.79B | -15.09% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivozon Pharmaceutical | 193.99B |
| GREEN CROSS WellBeing | 164.50B |
| Kyung Dong Pharmaceutical | 152.76B |
| PHARMARESEARCH BIO | 147.16B |
| DongKoo Bio & Pharma | 140.08B |
| OPTUS Pharmaceutical | 133.76B |
| Pharos iBio | 127.78B |
| HYUNDAI BIOLAND | 126.00B |